Beleave Inc (CNSX:BE) traded up 6.7% during trading on Thursday . The company traded as high as $0.09 and last traded at $0.08. 402,977 shares traded hands during mid-day trading, an increase of ∞ from the average session volume of 0 shares. The stock had previously closed at $0.08.
Separately, Fundamental Research dropped coverage on Beleave in a research report on Wednesday, March 13th. They issued a “buy” rating and a $0.60 price target for the company.
The stock’s 50-day simple moving average is $0.09.
Beleave Inc, together with its subsidiaries, cultivates, produces, and sells tetrahydrocannabinol and cannabidiol medical cannabis in Canada and Colombia. The company produces cannabis oils and extracts for medical purposes. It also operates a network of medical cannabis clinics under the Medi-Green banner.
Further Reading: Dividend Stocks – Are They Right For You?
Receive News & Ratings for Beleave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beleave and related companies with MarketBeat.com's FREE daily email newsletter.